Thesis Raises Total of $13.5 Million in Funding
Thesis is the company that offers a customized approach to cognitive performance products based on your unique brain chemistry.
Is it a placebo? Is it not a placebo? Thesis and Unilever think the answer is no. The investment was interestingly led by a partner at Unilever Ventures which gives the brand a potential future exit as well. The company originally came out of New York-based accelerator XRC.
Business Wire: Thesis, the First High Quality and Customized Nootropics Solution, Raises Total of $13.5 Million in Funding